Chengdu Huasun Technology Group (SZSE:000790) ROCE % : 3.07% (As of Mar. 2024)

View and export this data going back to 1998. Start your Free Trial

What is Chengdu Huasun Technology Group ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Chengdu Huasun Technology Group's annualized ROCE % for the quarter that ended in Mar. 2024 was 3.07%.

Chengdu Huasun Technology Group ROCE % Historical Data

The historical data trend for Chengdu Huasun Technology Group's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chengdu Huasun Technology Group ROCE % Chart

Chengdu Huasun Technology Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

8.69

4.88

6.58

4.26

3.40

Chengdu Huasun Technology Group Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															1.91	6.48	4.05	0.65	3.07

Chengdu Huasun Technology Group ROCE % Calculation

Chengdu Huasun Technology Group's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	39.222	/	( ( (1677.058 - 548.389)	+	(2133.479 - 953.185) )	/ 2 )
	=	39.222	/	( (1128.669	+	1180.294)	/ 2 )
	=	39.222	/	1154.4815
	=	3.40 %

Chengdu Huasun Technology Group's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	36.584	/	( ( (2133.479 - 953.185)	+	(2131.734 - 928.674) )	/ 2 )
	=	36.584	/	( ( 1180.294	+	1203.06 )	/ 2 )
	=	36.584	/	1191.677
	=	3.07 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Chengdu Huasun Technology Group (SZSE:000790) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Chengdu Huasun Technology Group ROCE % Related Terms

Thank you for viewing the detailed overview of Chengdu Huasun Technology Group's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Chengdu Huasun Technology Group (SZSE:000790) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chengdu Huasun Technology Group Inc Ltd (SZSE:000790) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

1168 Fuxin Avenue, High-tech Zone (West District), No. 101, 1st Floor, Building 2, Sichuan, Chengdu, CHN, 611731

Website

http://www.huasungrp.com

Chengdu Huasun Technology Group Inc Ltd, formerly Chengdu Taihe Health Technology Group Inc Ltd is engaged in the production and distribution of traditional Chinese medicines and chemical drugs in China. It is also involved in veterinary drugs, biological vaccines, and modern steel products.

Executives

Huang Xue	Director
Wang Ren Guo	Directors, executives
Ye Jing	Executives
Jiang Li	Executives
Bo Jian Ping	Executives
Wang Tian Xiang	Executives
Tang Ji Ying	Executives
Li Jian Hua	Executives
Wan Fang	Executives
Wei Yi Guo	Executives
Chen Zhong Qiao	Director

Chengdu Huasun Technology Group (SZSE:000790) Headlines

No Headlines